Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Myeloma
      • Highlights from BCD
      • COVID-19 & Cancer Resource Center
  • For Authors
    • Information for Authors
    • Author Services
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Blood Cancer Discovery
Blood Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Myeloma
      • Highlights from BCD
      • COVID-19 & Cancer Resource Center
  • For Authors
    • Information for Authors
    • Author Services
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity

Charles R. Schmidt, Nicholas J. Achille, Aravinda Kuntimaddi, Adam M. Boulton, Benjamin I. Leach, Shubin Zhang, Nancy J. Zeleznik-Le and John H. Bushweller
Charles R. Schmidt
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J. Achille
2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aravinda Kuntimaddi
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam M. Boulton
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin I. Leach
2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin I. Leach
Shubin Zhang
2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy J. Zeleznik-Le
2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
3Department of Medicine, Loyola University Chicago, Maywood, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jhb4v@virginia.edu nzelezn@luc.edu
John H. Bushweller
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John H. Bushweller
  • For correspondence: jhb4v@virginia.edu nzelezn@luc.edu
DOI: 10.1158/2643-3230.BCD-20-0036 Published September 2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2020 to March 2021

AbstractFull-text HTMLPDF
Total884946618

Cited By

Article Information

Volume 1, Issue 2, pp. 162-177

DOI 
https://doi.org/10.1158/2643-3230.BCD-20-0036

Published By 
American Association for Cancer Research Journals
Print ISSN 
2643-3230
Online ISSN 
2643-3249
History 
  • Received March 13, 2020
  • Revision received April 22, 2020
  • Accepted May 11, 2020
  • Published first July 7, 2020.

Article Versions

  • Previous version (July 7, 2020 - 05:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Charles R. Schmidt1,
  2. Nicholas J. Achille2,
  3. Aravinda Kuntimaddi1,
  4. Adam M. Boulton1,
  5. Benjamin I. Leach1,
  6. Shubin Zhang2,
  7. Nancy J. Zeleznik-Le2,3,* and
  8. John H. Bushweller1,*
  1. 1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia.
  2. 2Department of Cancer Biology, Loyola University Chicago, Maywood, Illinois.
  3. 3Department of Medicine, Loyola University Chicago, Maywood, Illinois.
  1. ↵*Corresponding Authors:
    John H. Bushweller, University of Virginia, P.O. Box 800736, 1330 Jefferson Park Avenue, Charlottesville, VA 22903. Phone: 434-243-6409; Fax: 434-982-1616; E-mail: jhb4v{at}virginia.edu; and Nancy J. Zeleznik-Le, Loyola University Chicago, 2160 S. First Avenue, Bldg. 112, Rm. 337, Maywood, IL 60153. E-mail: nzelezn{at}luc.edu
  • Current address for B.I. Leach: Department of Radiology, University of California, San Diego, La Jolla, California.

View Full Text
PreviousNext
Back to top
Blood Cancer Discovery: 1 (2)
September 2020
Volume 1, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Blood Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
(Your Name) has forwarded a page to you from Blood Cancer Discovery
(Your Name) thought you would be interested in this article in Blood Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
Charles R. Schmidt, Nicholas J. Achille, Aravinda Kuntimaddi, Adam M. Boulton, Benjamin I. Leach, Shubin Zhang, Nancy J. Zeleznik-Le and John H. Bushweller
Blood Cancer Discov September 1 2020 (1) (2) 162-177; DOI: 10.1158/2643-3230.BCD-20-0036

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity
Charles R. Schmidt, Nicholas J. Achille, Aravinda Kuntimaddi, Adam M. Boulton, Benjamin I. Leach, Shubin Zhang, Nancy J. Zeleznik-Le and John H. Bushweller
Blood Cancer Discov September 1 2020 (1) (2) 162-177; DOI: 10.1158/2643-3230.BCD-20-0036
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Methods
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A TFEB–IDH Epigenetic Circuit Controls AML Cell Fate
  • Synthetic Lethality by TET Dioxygenase Inhibition
  • Vulnerabilities in a Myd88/BCL2-Driven DLBCL Mouse Model
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Blood Cancer Discovery

  • About the Journal
  • Editors
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Blood Cancer Discovery
eISSN: 2643-3249
ISSN: 2643-3230

Advertisement